Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
about
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptorsEBNA2 and activated Notch induce expression of BATFStructural and Functional Characterization of a Complex between the Acidic Transactivation Domain of EBNA2 and the Tfb1/p62 Subunit of TFIIHProtein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.Functional interactions between an atypical NF-kappaB site from the rat CYP2B1 promoter and the transcriptional repressor RBP-Jkappa/CBF1.Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and Rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15).Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structureThe Epstein-Barr virus promoter initiating B-cell transformation is activated by RFX proteins and the B-cell-specific activator protein BSAP/Pax5Sequence and functional analysis of EBNA-LP and EBNA2 proteins from nonhuman primate lymphocryptovirusesNotch1IC partially replaces EBNA2 function in B cells immortalized by Epstein-Barr virus.Protein-DNA binding and CpG methylation at nucleotide resolution of latency-associated promoters Qp, Cp, and LMP1p of Epstein-Barr virusEpstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade.C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7.The human J kappa recombination signal sequence binding protein (RBP-J kappa) targets the Epstein-Barr virus EBNA2 protein to its DNA responsive elements.Regulation of Sp100A subnuclear localization and transcriptional function by EBNA-LP and interferon.The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoterEpstein-Barr virus infection in humans: from harmless to life endangering virus-lymphocyte interactions.EBNA2 interferes with the germinal center phenotype by downregulating BCL6 and TCL1 in non-Hodgkin's lymphoma cellsContribution of conserved amino acids in mediating the interaction between EBNA2 and CBF1/RBPJkAn EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP geneEpstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappaoriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines.Epstein-Barr virus latent membrane protein (LMP1) is not sufficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival.The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein.Marked, transient inhibition of expression of the Epstein-Barr virus latent membrane protein gene in Burkitt's lymphoma cell lines by electroporation.Identification of a negative element in the human vimentin promoter: modulation by the human T-cell leukemia virus type I Tax proteinImmune regulation in Epstein-Barr virus-associated diseasesVariable expression of latent membrane protein in nasopharyngeal carcinoma can be related to methylation status of the Epstein-Barr virus BNLF-1 5'-flanking region.Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts.Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter.Simian virus 40 T antigen activates the late promoter by modulating the activity of negative regulatory elementsEpstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element.An Epstein-Barr virus nuclear protein 2 domain essential for transformation is a direct transcriptional activator.Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.Identification of a novel protein encoded by the BamHI A region of the Epstein-Barr virus.EBNA2 amino acids 3 to 30 are required for induction of LMP-1 and immortalization maintenance.c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1.Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.B-cell proliferation and induction of early G1-regulating proteins by Epstein-Barr virus mutants conditional for EBNA2.The Spi-1/PU.1 and Spi-B ets family transcription factors and the recombination signal binding protein RBP-J kappa interact with an Epstein-Barr virus nuclear antigen 2 responsive cis-element.
P2860
Q24314660-33419693-D2FF-45DD-A038-113A06CE088FQ24679432-B27D04E4-822D-4FEC-8175-73D4F39A9A21Q27682610-580BBB1D-C754-4855-A6B3-763AC088F8D1Q28114910-31064B80-9D5F-4F02-885E-3500D19453C6Q28579505-7D993FBC-5F64-42BC-85F5-9F8BE05325DFQ33639938-A7C296D1-FB4C-4B86-A3CA-1877B8792A93Q33643991-B0DE2033-8BD3-4134-803D-FE4CF89C19B5Q33787243-F89825CC-979C-4D60-AAB1-CC7A1C8C8A46Q33795078-47674579-8823-4300-BAE4-01BEECF980E5Q33842309-26A8D397-8479-40E4-96BC-6456177266C3Q33865166-92C583A8-1D60-40D0-BED3-68CE8B0C36BDQ33887684-81C3F3D5-3D7D-4648-98B1-6DDFE96B18EEQ33998709-83CB7B9F-DF9B-46F6-B046-B5BD91ED6F0EQ34327455-D96D3170-D729-483B-8D2C-55E90368B437Q34334212-07E7D9C4-3022-44C1-A9BA-EF1FF5C51C56Q34355226-8B394C29-AA43-47CB-A696-F45869E18021Q34576340-222AF344-63C8-41B7-8FD6-F50B095E6E46Q35784734-615B4238-0C5B-4079-BE4C-81EC5F0A47ADQ35835726-4445685F-176D-4095-8F48-E4149F6A9C4CQ35838226-FE9501A2-2741-43A9-A800-DE979ABBC166Q35839108-00AB8C10-0DD2-41EA-A61D-532A1EF975F6Q35867579-B8C58F38-543C-4398-97B8-0C8762EC9799Q35917481-0195BFFB-0697-41A2-9F7B-44CD74DD7981Q36581891-3A6E1350-F3C6-43B0-BA7F-2B569B29D5C7Q36654123-CD4C24E5-58F2-461A-A556-15C6D3213F3CQ36658429-7193DDC7-0D67-489A-8F1A-BBCA5C7C9AFAQ36669953-3CDFA6ED-AF95-4F9C-B909-31E3F5192FE7Q36682729-2364005D-567A-4B08-B2A7-AECF625136B0Q36696963-DA2A21E5-099F-4702-BF24-A7B6C3612FC6Q36697355-0D3E5550-4FAC-4125-87FB-D19F188EFC8CQ36697871-2F8FC559-B23F-4971-94EA-CF36036D7E5DQ36797190-82E118DF-C70F-467F-A64B-8A110C365642Q36820857-293EC6FC-FB07-4E01-8EB8-949ECBCE2652Q36828413-BA46C74C-48D6-4DE8-A84E-91766C94E86CQ36849568-021A9B72-A3FA-4C18-A762-D12C050BA47AQ37093792-7FF5C591-6005-43B6-85C9-B115F501C232Q37340989-0AA70853-6B28-4BBA-9F90-E57A18426670Q37557660-477E6A85-1FEE-48E2-BDB9-FC58E68308BDQ37693393-5527E82E-E51A-47CC-BE1E-F39ED46CEBE1Q38301679-1837E6B7-2E07-4671-9492-0A869EB20116
P2860
Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element.
description
1990 nî lūn-bûn
@nan
1990 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1990 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
name
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@ast
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@en
type
label
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@ast
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@en
prefLabel
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@ast
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@en
P2093
P2860
P356
P1476
Epstein-Barr virus-encoded nuc ...... a negative regulatory element.
@en
P2093
P2860
P304
P356
10.1073/PNAS.87.19.7390
P407
P577
1990-10-01T00:00:00Z